Related Experiment Video
Updated: Jun 19, 2025

07:18
Author Spotlight: A Unique Mouse Model of Asphyxia-Induced Cardiac Arrest
Published on: April 14, 2023
1.7K
Innate immune memory after brain injury drives inflammatory cardiac dysfunction
Alba Simats1, Sijia Zhang2, Denise Messerer3
1Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany; Cerebrovascular Research Laboratory, Institute of Biomedical Research of Barcelona (IIBB), Spanish National Research Council (CSIC), Barcelona, Spain.
Cell
|July 23, 2024
Summary
Stroke survivors may develop heart problems due to lingering immune system changes. Targeting interleukin-1 beta (IL-1β) and monocyte movement offers a new way to prevent these secondary stroke complications.
Area of Science:
- Immunology
- Neurology
- Cardiology
Background:
- Stroke's long-term impact includes chronic comorbidities.
- Systemic immune responses post-stroke are not well understood.
- Myeloid innate immune memory is a potential cause of remote organ dysfunction.
Purpose of the Study:
- To investigate the role of systemic immunity in post-stroke comorbidities.
- To identify immunological mechanisms driving remote organ dysfunction after stroke.
- To explore targeted immunotherapies for secondary stroke prevention.
Main Methods:
- Single-cell sequencing to analyze immune cell changes.
- In vivo mouse models of stroke and cardiac dysfunction.
- Analysis of cardiac tissue from mice and human stroke patients.
- Interleukin-1 beta (IL-1β) neutralization and CCR2/5 inhibition.
Main Results:
- Persistent pro-inflammatory changes in monocytes/macrophages observed up to 3 months post-stroke.
- Cardiac fibrosis and dysfunction were identified in mice and human patients.
- IL-1β drives epigenetic changes in innate immune memory, inducing cardiac dysfunction.
- Blocking IL-1β or CCR2/5 prevented post-stroke cardiac dysfunction.
Conclusions:
- Myeloid innate immune memory contributes to remote organ dysfunction after stroke.
- IL-1β is a key mediator of stroke-induced cardiac complications.
- Targeting IL-1β and monocyte trafficking offers a therapeutic strategy for secondary stroke prevention.

